Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - IMLAY JOHN P JR
Last Updated 
6-Nov-09
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

IMLAY JOHN P JR: Declared Holdings
Company/RelationshipReportedShares  Ownership
IMS HEALTH INC
Director
NYSE:RX
(historical quotes, profile, SEC, other insiders)
21-Apr-0991,990  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
21-Apr-09 531RX Acquisition (Non Open Market) at $13.43 per share.
(Value of $7,131)
10-Feb-09 487RX Acquisition (Non Open Market) at $14.64 per share.
(Value of $7,129)
23-Jan-09 53RX Acquisition (Non Open Market) at $14.08 per share.
(Value of $746)
16-Dec-08 101RX Acquisition (Non Open Market) at $14.83 per share.
(Value of $1,497)
21-Oct-08 419RX Acquisition (Non Open Market) at $15.23 per share.
(Value of $6,381)
20-Oct-08 49RX Acquisition (Non Open Market) at $15.28 per share.
(Value of $748)
30-Sep-08 40RX Acquisition (Non Open Market) at $18.60 per share.
(Value of $744)
15-Jul-08 305RX Acquisition (Non Open Market) at $20.90 per share.
(Value of $6,374)
26-Jun-08 33RX Acquisition (Non Open Market) at $22.74 per share.
(Value of $750)
15-Apr-08 5,969RX Acquisition (Non Open Market) at $22.58 per share.
(Value of $134,780)
12-Feb-08 293RX Acquisition (Non Open Market) at $24.35 per share.
(Value of $7,134)
28-Jan-08 35RX Acquisition (Non Open Market) at $21.46 per share.
(Value of $751)
18-Dec-07 33RX Acquisition (Non Open Market) at $22.45 per share.
(Value of $740)
17-Dec-07 34RX Acquisition (Non Open Market) at $22.37 per share.
(Value of $760)


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?